List of Figures
Figure 1: Versatile Innovation in Immunology, US, Innovation Trends in Product Approvals, 1987–2014 6
Figure 2: Versatile Innovation in Immunology, US, Sales Performance of First-in-Class and Non-First-in-Class Products Post Marketing Approval, 2006–2013 8
Figure 3: Versatile Innovation in Immunology, Global, Overall Pharmaceutical Industry Pipeline by Therapy Area and Breakdown of Immunology Pipeline by Indication, 2016 17
Figure 4: Versatile Innovation in Immunology, Global, Pipeline for Immunology by Stage of Development and Molecule Type, 2016 18
Figure 5: Versatile Innovation in Immunology, Global, Pipeline for Immunology by Molecular Target, 2016 20
Figure 6: Versatile Innovation in Immunology, Global, Pipeline and Marketed Products for Immunology by Molecular Target Category, 2016 21
Figure 7: Versatile Innovation in Immunology, Global, Overall Pharmaceutical Industry First-in-Class Pipeline by Therapy Area and Breakdown of Immunology First-in-Class Pipeline by Indication, 2016 22
Figure 8: Versatile Innovation in Immunology Therapeutics Market, Global, First-in-Class Pipeline for Immunology by Stage of Development and Molecule Type, 2016 23
Figure 9: Versatile Innovation in Immunology, Global, First-in-Class Pipeline for Immunology by Molecular Target, 2016 24
Figure 10: Versatile Innovation in Immunology, Global, Pipeline for Immunology by First-in-Class Status and Molecular Target Class, 2016 25
Figure 11: Versatile Innovation in Immunology, Global, Distribution of First-in-Class and Established Products by Stage of Development (%), 2016 26
Figure 12: Versatile Innovation in Immunology, Global, Distribution of First-in-Class and Established Products by Molecular Target Class (%), 2016 26
Figure 13: Versatile Innovation in Immunology, Global, First-in-Class Immunology Pipeline Products by Number of Indications, 2016 26
Figure 14: Versatile Innovation in Immunology, Global, Pipeline for Key Immunology Indications by Molecular Target, 2016 27
Figure 15: Versatile Innovation in Immunology, Global, Versatile Pipeline for Immunology by Stage of Development and Molecule Type, 2016 28
Figure 16: Versatile Innovation in Immunology, Global, Versatile First-in-Class Pipeline Immunology by Molecular Target, 2015 29
Figure 17: Versatile Innovation in Immunology, Global, First-in-Class Pipeline for Immunology by Versatile Status and Molecular Target Class, 2016 30
Figure 18: Versatile Innovation in Immunology, Global, First-in-class Pipeline for Immunology Indications (Part 1), 2016 31
Figure 19: Versatile Innovation in Immunology, Global, First-in-class Pipeline for Immunology Indications (Part 2), 2016 32
Figure 20: Versatile Innovation in Immunology, Global, First-in-class Pipeline for Immunology Indications (Part 3), 2016 33
Figure 21: Versatile Innovation in Immunology, Global, First-in-class Pipeline for Immunology Indications (Part 4), 2016 34
Figure 22: Versatile Innovation in Immunology, Global, First-in-Class Matrix, 2016 (part 1) 37
Figure 23: Versatile Innovation in Immunology, Global, First-in-Class Matrix, 2016 (part 2) 38
Figure 24: Versatile Innovation in Immunology, Global, First-in-Class Matrix, 2016 (part 3) 39
Figure 25: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 43
Figure 26: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 43
Figure 27: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 43
Figure 28: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 45
Figure 29: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 47
Figure 30: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 48
Figure 31: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 50
Figure 32: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 51
Figure 33: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 52
Figure 34: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX, 2016 54
Figure 35: Versatile Innovation in Immunology, Global, Pipeline Programs Targeting XXX , 2016 55
Figure 36: Versatile Innovation in Immunology, Global, Licensing Deals by Stage of Development, 2006–2015 56
Figure 37: Versatile Innovation in Immunology, Global, Industry-Wide Licensing Deals by Deal Value, Upfront Payment Value, Stage of Development and First-in-Class Status ($m), 2006–2015 57
Figure 38: Versatile Innovation in Immunology, Global, Licensing Deals by Region, Value and Year, 2006–2016 58
Figure 39: Versatile Innovation immunology, Global, Licensing Deals by Stage of Development, Deal Value and Upfront Payment Value, 2006–2016 59
Figure 40: Versatile Innovation in Immunology, Global, Licensing Deals by Molecule Type, 2006–2016 60
Figure 41: Immunology, Global, Licensing Deals by Molecular Target, 2006–2016 61
Figure 42: Versatile Innovation in Immunology, Global, Licensing Deals Valued Above $100m, 2006–2016 62
Figure 43: Versatile Innovation in Immunology, Global, Co-development Deals by Region, Value and Year, 2006–2016 63
Figure 44: Immunology, Global, Co-development Deals by Stage of Development, Deal Value and Upfront Payment Value, 2006–2016 64
Figure 45: Versatile Innovation in Immunology, Global, Co-development Deals by Molecule Type, 2006–2016 65
Figure 46: Versatile Innovation in Immunology, Global, Co-development Deals by Molecular Target, 2006–2016 66
Figure 47: Versatile Innovation in Immunology, Global, Co-development Deals Valued Above $100m, 2006–2016 67
Figure 48: Versatile Innovation in Immunology, Global, List of First-in-Class Pipeline Products with and Without Prior Deal Involvement, 2016 68
Figure 49: Versatile Innovation in Immunology, Global, List of First-in-Class Pipeline Products with and Without Prior Deal Involvement, 2016 69
Figure 50: Versatile Innovation in Immunology, Global, List of First-in-Class Pipeline Products with and Without Prior Deal Involvement, 2016 70
Figure 51: Versatile Innovation in Immunology, Global, List of First-in-Class Pipeline Products with and Without Prior Deal Involvement, 2016 71